CMS approves Medicaid waivers to treat substance use disorders
The Centers for Medicare & Medicaid Services last week Section 1115 waivers allowing Minnesota and Nebraska to implement demonstration projects to increase access and treatment for Medicaid beneficiaries with opioid and other substance use disorders. Both states will receive Medicaid matching funds for treatment in facilities that meet the definition of an institution for mental diseases, which include hospitals and other residential treatment facilities with more than 16 beds that are primarily engaged in diagnosis, treatment or care of persons with mental diseases. CMS outlined additional waiver opportunities last November for states to treat SUDs and mental illness.
Related News Articles
Headline
Twelve House Republicans April 14 sent a letter to House leadership voicing their opposition to potential Medicaid cuts. The lawmakers said they support “…
Headline
The AHA yesterday released two new resources highlighting the significance of Medicaid and the potential impacts if Congress makes cuts to the program. An…
Headline
The Centers for Medicare & Medicaid Services April 10 announced that it does not intend to approve new or extend existing requests for federal funds to…
Perspective
Congressional lawmakers are heading home for a two-week district work period after both the Senate and House passed a revised budget resolution for fiscal year…
Headline
The Coalition to Strengthen America’s Healthcare today launched a new television and digital advertisement as part of its Medicaid campaign. The ad highlights…
Headline
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in…